» Articles » PMID: 38541685

Prevalence and Clinical Management of Adrenal Tumour-Related Hyperandrogenism: A Narrative Review

Overview
Journal Life (Basel)
Specialty Biology
Date 2024 Mar 28
PMID 38541685
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperandrogenism is a condition in which the levels of androgen hormones in the blood are significantly increased and could be of an adrenal or ovarian origin. The adrenal androgens, normally secreted by the zona reticularis, are steroid hormones with weak androgen activity. The causes of hyperandrogenism are diverse and could be endogenous and exogenous. Androgen excess affecting different tissues and organs results in clinical features such as acne, hirsutism, virilization, and reproductive dysfunction such as oligomenorrhoea/amenorrhoea. Although androgen excess is rarely associated with adrenal tumours, it is important as it could be predictive of malignancy. A careful evaluation of the androgen pattern, also in patients with clear signs of hyperandrogenism, could be useful. Laboratory evaluation should focus on measuring total testosterone levels, followed by the estimation of other androgens such as dehydroepiandrosterone and androstenedione, and using visualisation procedures in the further management. The treatment of adrenal hyperandrogenism is eminently surgical, in consideration of the frequent malignant origin. The aim of this review is to elaborate and summarize the prevalence and clinical management of hyperandrogenism of an adrenal origin by describing the physiological mechanisms of adrenal androgen steroidogenesis, the clinical manifestations of hyperandrogenism with a special reference to hyperandrogenism in adrenal adenomas and carcinomas, and the diagnostic methods that will lead us to establishing the correct diagnosis and different treatment options to manage this condition according to the clinical presentation of the patient.

References
1.
Kumarendran B, OReilly M, Manolopoulos K, Toulis K, Gokhale K, Sitch A . Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med. 2018; 15(3):e1002542. PMC: 5873722. DOI: 10.1371/journal.pmed.1002542. View

2.
Ueland G, Grinde T, Methlie P, Kelp O, Lovas K, Husebye E . Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas. Endocr Connect. 2020; 9(10):963-970. PMC: 7576642. DOI: 10.1530/EC-20-0419. View

3.
Martin K, Anderson R, Chang R, Ehrmann D, Lobo R, Murad M . Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018; 103(4):1233-1257. DOI: 10.1210/jc.2018-00241. View

4.
Rosol T, Yarrington J, LATENDRESSE J, Capen C . Adrenal gland: structure, function, and mechanisms of toxicity. Toxicol Pathol. 2001; 29(1):41-8. DOI: 10.1080/019262301301418847. View

5.
Markopoulos M, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos G . Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. J Clin Endocrinol Metab. 2010; 96(3):623-31. DOI: 10.1210/jc.2010-0130. View